16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases
Key Takeaways
Under the 2017 AAP/EFP World Workshop Classification, Peri-Implant Mucositis is defined as plaque-induced soft tissue inflammation (BOP/suppuration) without bone loss beyond initial remodeling, whereas Peri-Implantitis involves mucosal inflammation combined with progressive crestal bone loss.
Diagnostic criteria for Peri-Implantitis in the absence of baseline data require Bleeding on Probing (BOP) and/or suppuration, probing depths ≥6.0 mm, and crestal bone levels ≥3.0 mm apical to the intra-mucosal portion of the implant.
Major modifiable and non-modifiable risk factors include a history of severe periodontitis (odds ratio 2–5x), tobacco smoking, uncontrolled diabetes, lack of keratinized mucosa (<2.0 mm), and subgingival entrapment of residual restorative cement.
Peri-Implant Mucositis is fully reversible with non-surgical mechanical debridement, glycine/erythritol air-polishing, and chemical plaque control; conversely, non-surgical therapy alone shows low predictability in resolving Peri-Implantitis.
Surgical management of Peri-Implantitis incorporates open flap debridement, implant surface decontamination (titanium brushes, citric acid, air-polishing), and either resective surgery with implantoplasty or regenerative Guided Bone Regeneration (GBR), guided by the Cumulative Interceptive Supportive Therapy (CIST) protocol.
16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases
Peri-implant diseases represent plaque-associated inflammatory conditions occurring in the tissues surrounding dental implants. Defined globally by the 2017 AAP/EFP World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions and endorsed by the Australian Society of Periodontology (ASP) and Dental Board of Australia (DBA), peri-implant conditions range from reversible soft tissue inflammation to progressive, destructive bone loss. For candidates taking the ADC Written Examination, a thorough understanding of the diagnostic definitions, risk factor profiles, non-surgical interceptive protocols, surgical decontamination techniques, and explantation criteria is essential.
1. 2017 AAP/EFP Classification & Diagnostic Criteria
The 2017 World Workshop established standardized, evidence-based diagnostic criteria distinguishing peri-implant health, peri-implant mucositis, and peri-implantitis.
| Classification | Visual Inflammation | Bleeding on Probing (BOP) / Suppuration | Probing Depth (PD) | Radiographic Crestal Bone Levels |
|---|---|---|---|---|
| Peri-Implant Health | Absence of erythema, edema, or swelling. | Absence of BOP and suppuration. | Stable baseline PDs (typically ≤3–4 mm). | Absence of bone loss beyond physiological remodeling (≤1.5–2.0 mm post-loading). |
| Peri-Implant Mucositis | Presence of erythema, edema, and mucosal swelling. | Presence of BOP and/or suppuration. | Increased PD compared to baseline due to swelling. | Absence of progressive bone loss beyond initial physiological remodeling. |
| Peri-Implantitis | Visual mucosal inflammation and swelling. | Presence of BOP and/or suppuration upon probing. | Increased PD (typically ≥6.0 mm) compared to baseline. | Progressive crestal bone loss extending beyond physiological remodeling. |
Diagnostic Cutoffs when Baseline Radiographs / Probing Depths are ABSENT:
When previous clinical records or baseline radiographs are unavailable, the 2017 AAP/EFP classification mandates diagnosing Peri-Implantitis based on the following triad:
- Presence of Bleeding on Probing (BOP) and/or suppuration.
- Probing Depths ≥6.0 mm.
- Radiographic bone levels ≥3.0 mm apical to the most coronal portion of the intra-mucosal part of the implant.
2. Etiology & Risk Factors / Indicators
Peri-implantitis is an infectious disease driven by polymicrobial biofilm dysbiosis, characterized by a shift toward anaerobic Gram-negative periodontopathogens (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Fusobacterium nucleatum). Several local and systemic risk factors significantly increase patient susceptibility.
+-----------------------------------------------------------------------------------------+
| RISK FACTORS & INDICATORS FOR PERI-IMPLANTITIS |
+-----------------------------------------------------------------------------------------+
| Patient-Related | History of severe periodontitis (OR 2-5x), Smoking, Uncontrolled Diabetes |
| Local / Tissue | Lack of Keratinized Mucosa (<2.0 mm), Poor oral hygiene / compliance |
| Iatrogenic | Subgingival RESIDUAL CEMENT entrapment, Implant malposition |
+-----------------------------------------------------------------------------------------+
- History of Periodontitis: The strongest patient-level risk factor. Untreated or poorly managed periodontitis provides a reservoir of pathogenic bacteria that cross-colonize peri-implant sites.
- Subgingival Excess Restorative Cement (Iatrogenic): Retained subgingival cement following cementation of implant crowns creates a rough, porous substrate for heavy bacterial colonization. This frequently triggers acute, rapid suppurative breakdown and severe localized bone loss.
- Lack of Keratinized Mucosa (<2.0 mm): A band of keratinized tissue <2.0 mm around transmucosal abutments increases patient discomfort during brushing, plaque accumulation, mucosal recession, and tissue inflammation.
- Implant Malposition & Uncleanable Prosthetic Contours: Implants placed too close together (<3.0 mm) or crowns featuring concave, non-cleansable emergence profiles prevent effective mechanical plaque control by the patient.
3. Non-Surgical Management Protocols
Non-surgical therapy is the mandatory first-line treatment for peri-implant mucositis and serves as the initial phase of peri-implantitis control.
A. Peri-Implant Mucositis Treatment (Fully Reversible)
- Mechanical Debridement: Complete removal of biofilm and calculus using pure titanium scalers, carbon-fiber curettes, or subgingival glycine/erythritol air-polishing.
- Removal of Iatrogenic Triggers: Elimination of overhanging crown margins and complete removal of subgingival residual cement.
- Antiseptic Rinses: 0.12% Chlorhexidine gluconate mouthrinse twice daily for 2 to 3 weeks.
- Prosthetic Modification: Recontouring crown contours if they impede interdental brushing.
- Prognosis: High predictability; full resolution of inflammation and return to health.
B. Non-Surgical Treatment of Peri-Implantitis (Limited Predictability)
- While non-surgical debridement reduces soft tissue inflammation, it rarely achieves complete disease resolution or re-osseointegration in deeper peri-implantitis pockets (≥6.0 mm).
- Adjunctive Antimicrobials: Controlled-release local antimicrobials (e.g., Minocycline microspheres or Doxycycline hyclate gel) placed into deep pockets provide modest short-term probing depth reductions.
- Systemic Antibiotics: Routine systemic antibiotics during non-surgical therapy are not recommended due to limited efficacy and antimicrobial resistance concerns.
4. Surgical Interventions for Peri-Implantitis
When non-surgical therapy fails to eliminate deep pockets (≥6.0 mm), suppuration, and active BOP after 6 to 12 weeks, surgical intervention is indicated.
+-----------------------------------------------------------------------------------------+
| SURGICAL MANAGEMENT OF PERI-IMPLANTITIS |
+-----------------------------------------------------------------------------------------+
| Step 1: Open Flap Debridement (OFD) | Full-thickness mucoperiosteal flap reflection |
| Step 2: Surface Decontamination | Titanium brushes, Citric acid 24%, Air-polishing |
| Step 3A: Resective + Implantoplasty | Smoothing exposed threads (Non-esthetic zones) |
| Step 3B: Regenerative (GBR) | Bone graft + Barrier membrane (3-wall defects) |
+-----------------------------------------------------------------------------------------+
A. Step 1: Flap Reflection & Granulation Tissue Removal
- Full-thickness mucoperiosteal flaps are reflected buccally and lingually under local anesthesia.
- Inflammatory granulation tissue filling the intra-bony defect is completely curetted using titanium scalers.
B. Step 2: Implant Surface Decontamination (Critical Phase)
Decontamination of the contaminated, micro-rough titanium surface is necessary to render the surface biocompatible.
- Mechanical Decontamination: Rotary titanium brushes, subgingival glycine/erythritol air-polishing, or Er:YAG laser ablation.
- Chemical Decontamination: Application of 24% Citric Acid for 1 minute, 3% Hydrogen Peroxide, or Chlorhexidine 0.2% gel, followed by copious sterile saline irrigation.
C. Step 3: Selection of Surgical Modality
- Resective Surgery & Implantoplasty:
- Indications: Suprabony defects, 1-wall or 2-wall shallow bone defects, and non-esthetic areas (posterior mandible).
- Procedure: Apical positioning of the soft tissue flap combined with Implantoplasty—using diamond and carbide burs to smooth away the rough exposed titanium threads, leaving a polished surface that inhibits re-colonization by bacterial biofilm.
- Regenerative Surgery (Guided Bone Regeneration - GBR):
- Indications: Self-containing, deep intra-bony defects (3-wall or circumferential defects) in esthetic zones.
- Procedure: Filling the decontaminated defect with particulate bone graft (autogenous bone combined with xenograft/bovine bone mineral) and covering with a resorbable collagen barrier membrane to achieve re-osseointegration.
5. Cumulative Interceptive Supportive Therapy (CIST) & Explantation
The CIST Protocol offers a structured, step-wise clinical treatment matrix based on probing depth, bleeding, and bone loss severity.
| CIST Stage | Clinical Findings | Required Interceptive Treatment |
|---|---|---|
| Stage A | Probing Depth 3–4 mm, Bleeding on Probing (+) | Mechanical Debridement: Oral hygiene instruction, polishing, air-polishing. |
| Stage B | Probing Depth 4–5 mm, Bleeding on Probing (+) | Antiseptic Therapy: Stage A + Chlorhexidine 0.12% irrigation/rinse for 3 weeks. |
| Stage C | Probing Depth >5 mm, BOP (+), Bone Loss 2–4 mm | Antimicrobial Therapy: Stage A + B + Local controlled-release antibiotics. |
| Stage D | Probing Depth >5 mm, BOP (+), Bone Loss >4 mm | Surgical Therapy: Stage A + B + C + Open flap debridement, surface decontamination, and Resective/Regenerative surgery. |
Indications for Implant Explantation (Removal)
Implant retention is not always viable. Explantation is mandatory under the following conditions:
- Clinical Fixture Mobility: Pathognomonic for total loss of osseointegration.
- Extreme Bone Loss (>50% to 70% of implant length): Accompanied by refractory suppuration despite surgical intervention.
- Severe Implant Malposition: Renders the implant unrestorable or un-cleansable.
- Technique: Explantation should utilize reverse-torque extraction kits or ultra-thin trephine burs to preserve host bone for future site reconstruction.
According to the 2017 AAP/EFP World Workshop Classification, what specific combination of clinical findings establishes a diagnosis of Peri-Implantitis in a patient where baseline probing records and initial post-loading radiographs are unavailable?
Presence of bleeding on probing/suppuration, probing depths >= 6.0 mm, and bone levels >= 3.0 mm apical to the intra-mucosal portion of the implant
Absence of bleeding on probing, probing depths <= 3.0 mm, and horizontal bone loss < 1.0 mm
Bleeding on probing alone with probing depths of 4.0 mm and no radiographic evidence of crestal bone loss
Mobility of the prosthetic crown with intact interproximal bone crests and absence of suppuration
What is the critical clinical distinction between Peri-Implant Mucositis and Peri-Implantitis regarding disease progression and treatment outcome?
Peri-implant mucositis involves progressive alveolar bone destruction, whereas peri-implantitis is confined strictly to mucosal tissues
Peri-implant mucositis is fully reversible with non-surgical mechanical debridement, whereas peri-implantitis features irreversible bone loss and rarely resolves with non-surgical therapy alone
Peri-implant mucositis requires immediate surgical explantation, whereas peri-implantitis is managed exclusively with systemic antibiotics
Peri-implant mucositis occurs only around ceramic implants, whereas peri-implantitis is restricted to titanium implants
During open flap resective surgery for peri-implantitis in a non-esthetic posterior mandibular site, the clinician performs an implantoplasty. What is the primary objective of performing implantoplasty during this procedure?
To widen the internal thread diameter of the implant to accommodate a larger retaining screw
To apply a thick layer of bioactive glass to the exposed titanium surface
To mechanically smooth away exposed rough titanium threads, reducing surface roughness and inhibiting bacterial re-colonization
To induce immediate thermal necrosis of the surrounding host cortical bone
A patient presenting with a single-implant restoration exhibits deep probing depths of 7 mm, active suppuration, and radiographic bone loss of 3.5 mm (Stage C/D CIST). Non-surgical therapy has failed. The defect is a narrow, self-containing 3-wall intra-bony defect in the esthetic maxilla. Which surgical intervention is indicated?
Immediate explantation using a 10 mm trephine drill without bone grafting
Resective surgery with apical flap repositioning and aggressive removal of all buccal keratinized tissue
Subgingival chemical cauterization with concentrated silver nitrate without flap reflection
Regenerative surgery utilizing Guided Bone Regeneration (GBR) with bone graft material and a barrier membrane
Sections you finish are checked off in the contents.
You've completed this section
Continue exploring other exams